Frequencies of mutations showing escalating trend with the progression of the liver diseases from no liver fibrosis (nLF) or liver fibrosis (LF) to liver cirrhosis (LC) and hepatocellular carcinoma (HCC).

Significant mutations were indicated in bold (p≤0.05) and marginal significant values were represented in italics.Frequencies of mutations showing escalating trend with the progression of the liver diseases from no liver fibrosis (nLF) or liver fibrosis (LF) to liver cirrhosis (LC) and hepatocellular carcinoma (HCC).

显著性突变以加粗字体标注（p≤0.05），边际显著性结果以斜体字体表示。本数据集统计了随肝脏疾病进展（从无肝纤维化（nLF）、肝纤维化（LF）进展至肝硬化（LC）及肝细胞癌（HCC））呈现递增趋势的突变频率。